Enovis Corp (ENOV)
Official siteHEALTHCARE • MEDICAL DEVICES • NYSE
Market Cap: $1.60B
Last updated: Nov 17, 2026 at 4:20 PM ET
Enovis Corp (ENOV) Statistics
Enovis (ENOV) has a market cap of $1.60B and an enterprise value of $2.90B. It kept -22.83% of revenue as net income over the last 12 months. Its net debt of $1.31B equals 81.73% of its market cap.
Total Valuation
Enterprise value is 81.73% above the market cap, as debt exceeds cash.
| Market Cap | $1.60B |
|---|---|
| Enterprise Value | $2.90B |
| Latest price (Nov 17, 2026) | $27.20 |
Key Dates
The next earnings report is expected on Feb 24, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Feb 24, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 5, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 0.7x and 1.1x. Its year-end P/E ranged from 5.2x to 23.6x from 2016 to 2025.
| P/E Ratio | 8.0x |
|---|---|
| Forward P/E | 7.3x |
| P/S Ratio | 0.7x |
| Forward P/S | 0.7x |
| P/B Ratio | 1.1x |
| P/FCF Ratio | 22.6x |
| P/OCF Ratio | 6.2x |
| PEG Ratio | 1.3 |
Enterprise Valuation
Counting debt and cash, the company is valued at 41.3x free cash flow.
| EV / Sales | 1.3x |
|---|---|
| EV / FCF | 41.3x |
Price Statistics
The stock is down 9.30% over 52 weeks and trades 30.46% above its 50-day average.
| Beta (1Y) | 0.94 |
|---|---|
| 52-Week Change | -9.30% |
| 1-Month Change | +36.89% |
| 3-Month Change | +2.64% |
| 6-Month Change | +5.59% |
| 5-Year Change | -77.59% |
| 10-Year Change | -63.61% |
| Total Return (1Y) | -9.30% |
| Total Return (3Y CAGR) | -19.02% |
| Total Return (5Y CAGR) | -20.90% |
| Return vs SPY (1Y) | -15.24% |
| Max Drawdown (1Y) | -44.53% |
| Max Drawdown (3Y) | -72.68% |
| Sharpe Ratio (1Y) | -0.06 |
| Correlation with SPY (1Y) | 0.19 |
| 50-Day Average | $20.85 |
| 200-Day Average | $23.29 |
| 52-Week Range | $16.70 to $31.67 |
| RSI (14 Days) | 63.4 |
| Average Volume (20 Days) | 1.84M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 2.15x current liabilities, and total debt is 0.88x shareholder equity.
| Current Ratio | 2.15x |
|---|---|
| Quick Ratio | 1.08x |
| Debt / Equity | 0.88x |
| Debt / FCF | 18.95x |
| Interest Coverage | -14.52x |
Returns and Efficiency
Return on invested capital is -16.70% over the last 12 months, against a 5-year average of -12.49%.
| Return on Equity (ROE) | -35.26% |
|---|---|
| Return on Assets (ROA) | -14.09% |
| Return on Invested Capital (ROIC) | -16.70% |
| Return on Capital Employed (ROCE) | -14.88% |
| ROE (5Y Average) | -22.26% |
| ROA (5Y Average) | -9.69% |
| ROIC (5Y Average) | -12.49% |
| Asset Turnover | 0.56x |
| Inventory Turnover | 1.46x |
| Receivables Turnover | 5.30x |
| Cash Conversion Cycle | 238 days |
Scores
ENOV has an Altman Z-Score of 0.28, in the distress zone below 1.81, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 0.28 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 4 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $2.31B over the last 12 months is up 3.28% from the 12 months before.
| Revenue | $2.31B |
|---|---|
| Revenue Growth (YoY) | +3.28% |
| Gross Profit | $1.41B |
| Operating Income | -$474.86M |
| Pretax Income | -$501.90M |
| Net Income | -$526.52M |
| EBITDA | -$174.67M |
| EBIT | -$469.57M |
| Reported EPS (TTM) | $3.38 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 39.84% of the $3.74B in total assets.
| Cash and Equivalents | $13.04M |
|---|---|
| Total Debt | $1.32B |
| Net Debt | $1.31B |
| Net Debt Per Share | $22.62 |
| Working Capital | $667.74M |
| Shareholder Equity | $1.49B |
| Book Value Per Share | $25.88 |
| Tangible Book Value | -$302.79M |
| Total Assets | $3.74B |
| Total Liabilities | $2.24B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $189.46M of capital spending, operating cash flow left $69.56M of free cash flow.
| Operating Cash Flow | $259.02M |
|---|---|
| Capital Expenditures | $189.46M |
| Free Cash Flow | $69.56M |
| FCF Per Share | $1.21 |
| Depreciation and Amortization | $294.90M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -20.59%, against a 5-year average of -19.92%.
| Gross Margin | 61.31% |
|---|---|
| Operating Margin | -20.59% |
| Pretax Margin | -21.76% |
| Net Margin | -22.83% |
| EBITDA Margin | -7.57% |
| EBIT Margin | -20.36% |
| FCF Margin | 3.02% |
| Gross Margin (5Y Average) | 56.81% |
| Operating Margin (5Y Average) | -19.92% |
| Net Margin (5Y Average) | -17.82% |
Growth
Revenue grew 12.88% a year over 3 years, and EPS 13.28% a year.
| Revenue Growth (3Y CAGR) | +12.88% |
|---|---|
| Revenue Growth (5Y CAGR) | +14.94% |
| EPS Growth (3Y CAGR) | +13.28% |
| EPS Growth (5Y CAGR) | -4.57% |
| FCF Growth (5Y CAGR) | -36.11% |
| Book Value Per Share Growth (2Y CAGR) | -35.28% |
Dividends and Yields
ENOV does not pay a dividend. Its free cash flow yield is 4.43%.
| Earnings Yield | 12.50% |
|---|---|
| FCF Yield | 4.43% |
| Buyback Yield | -0.09% |
| Shareholder Yield | -0.09% |
Stock Splits
The last reverse split was on Apr 5, 2022.
| Last Split Date | Apr 5, 2022 |
|---|---|
| Split Type | Reverse split |
Peer Position
Against 6 similar companies, ENOV has the 6th highest P/E.
P/E RatioPeer median 30.7x
P/S RatioPeer median 2.3x
ROICPeer median -3.43%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +11.95%
| P/E Ratio | 8.0x vs 30.7x median |
|---|---|
| P/S Ratio | 0.7x vs 2.3x median |
| ROIC | -16.70% vs -3.43% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +3.28% vs +11.95% median |
Analyst Forecast
Consensus estimates put revenue growth at 4.34% and EPS growth at 2.45% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +4.34% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | +2.45% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About ENOV
What is ENOV's market cap?
Enovis has a market cap of $1.60B. Its enterprise value, which adds debt and subtracts cash, is $2.90B.
What is ENOV's P/E ratio?
Enovis has a trailing P/E ratio of 8.0x and a forward P/E of 7.3x.
How many shares of ENOV are outstanding?
Enovis has 57.69M shares outstanding. The count is up 0.88% from a year earlier.
Does ENOV pay a dividend?
No. Enovis does not pay a dividend.
How much debt does ENOV have?
Enovis has $1.32B of total debt and $13.04M of cash and equivalents, a net debt position of $1.31B.
ENOV pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors